These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Involvement of kappa-opioid receptors in visceral nociception in mice. Larsson MH; Bayati A; Lindström E; Larsson H Neurogastroenterol Motil; 2008 Oct; 20(10):1157-64. PubMed ID: 18643891 [TBL] [Abstract][Full Text] [Related]
7. Antinociceptive and adverse effects of mu- and kappa-opioid receptor agonists: a comparison of morphine and U50488-H. Gallantine EL; Meert TF Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):419-27. PubMed ID: 18699797 [TBL] [Abstract][Full Text] [Related]
8. Managing pain in chronic pancreatitis:therapeutic value of opioid treatment. Eisenberg E; Ståhl C; Drewes AM; Arendt-Nielsen L J Pain Palliat Care Pharmacother; 2007; 21(3):63-5. PubMed ID: 18032359 [TBL] [Abstract][Full Text] [Related]
9. The effect of kappa-opioid receptor agonists on tetrodotoxin-resistant sodium channels in primary sensory neurons. Su X; Castle NA; Antonio B; Roeloffs R; Thomas JB; Krafte DS; Chapman ML Anesth Analg; 2009 Aug; 109(2):632-40. PubMed ID: 19608841 [TBL] [Abstract][Full Text] [Related]
10. The emerging therapeutic roles of κ-opioid agonists. Jones MR; Kaye AD; Kaye AJ; Urman RD J Opioid Manag; 2016; 12(2):101-7. PubMed ID: 27194194 [TBL] [Abstract][Full Text] [Related]
11. Central and peripheral analgesic agents: chemical strategies for limiting brain penetration in kappa-opioid agonists belonging to different chemical classes. Giardina G; Clarke GD; Grugni M; Sbacchi M; Vecchietti V Farmaco; 1995 Jun; 50(6):405-18. PubMed ID: 7669179 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of novel peripherally restricted kappa-opioid receptor agonists. Kumar V; Guo D; Cassel JA; Daubert JD; Dehaven RN; Dehaven-Hudkins DL; Gauntner EK; Gottshall SL; Greiner SL; Koblish M; Little PJ; Mansson E; Maycock AL Bioorg Med Chem Lett; 2005 Feb; 15(4):1091-5. PubMed ID: 15686919 [TBL] [Abstract][Full Text] [Related]
13. Review article: visceral hypersensitivity in irritable bowel syndrome: molecular mechanisms and therapeutic agents. Akbar A; Walters JR; Ghosh S Aliment Pharmacol Ther; 2009 Sep; 30(5):423-35. PubMed ID: 19493256 [TBL] [Abstract][Full Text] [Related]
14. Analgesia from a peripherally active kappa-opioid receptor agonist in patients with chronic pancreatitis. Eisenach JC; Carpenter R; Curry R Pain; 2003 Jan; 101(1-2):89-95. PubMed ID: 12507703 [TBL] [Abstract][Full Text] [Related]
16. Effects of kappa opioid receptor agonists on attention as assessed by a 5-choice serial reaction time task in rats. Shannon HE; Eberle EL; Mitch CH; McKinzie DL; Statnick MA Neuropharmacology; 2007 Dec; 53(8):930-41. PubMed ID: 17959202 [TBL] [Abstract][Full Text] [Related]
17. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626 [TBL] [Abstract][Full Text] [Related]
18. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential. Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307 [TBL] [Abstract][Full Text] [Related]
19. Sex differences in opioid analgesia: clinical and experimental findings. Fillingim RB; Gear RW Eur J Pain; 2004 Oct; 8(5):413-25. PubMed ID: 15324773 [TBL] [Abstract][Full Text] [Related]
20. Kappa opioids and the modulation of pain. Kivell B; Prisinzano TE Psychopharmacology (Berl); 2010 Jun; 210(2):109-19. PubMed ID: 20372880 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]